Evidence map›Paper›PMID 30796108›Full record

ArticleDiabetes care2019

Gluten Intake and Risk of Islet Autoimmunity and Progression to Type 1 Diabetes in Children at Increased Risk of the Disease: The Diabetes Autoimmunity Study in the Young (DAISY).

Nicolai A Lund-Blix, Fran Dong, Karl Mårild, Jennifer Seifert, Anna E Barón, Kathleen C Waugh, Geir Joner, Ketil Størdal, German Tapia, Lars C Stene and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes care, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Observational
  12. Review
  13. Article
  14. Review
  15. Review
  16. Observational
  17. Type 1 diabetes-early life origins and changing epidemiology.The lancet. Diabetes & endocrinology · 2020
    Review
  18. Article
  19. Review
  20. The Challenges of Identifying Environmental Determinants of Type 1 Diabetes: In Search of the Holy Grail.Diabetes, metabolic syndrome and obesity : targets and therapy · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Nicolai A Lund-BlixDepartment of Chronic Diseases and Ageing, Norwegian Institute of Public Health, Oslo, Norway nicolai.andre.lund-blix@fhi.no.ORCID 0000-0002-9092-7867
Fran DongBarbara Davis Center, University of Colorado Anschutz Medical Campus, Aurora, CO.
Karl MårildDepartment of Chronic Diseases and Ageing, Norwegian Institute of Public Health, Oslo, Norway.
Jennifer SeifertDepartment of Epidemiology, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO.
Anna E BarónDepartment of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO.
Kathleen C WaughBarbara Davis Center, University of Colorado Anschutz Medical Campus, Aurora, CO.
Geir JonerDepartment of Pediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.
Ketil StørdalDepartment of Chronic Diseases and Ageing, Norwegian Institute of Public Health, Oslo, Norway.
German TapiaDepartment of Chronic Diseases and Ageing, Norwegian Institute of Public Health, Oslo, Norway.ORCID 0000-0002-1770-1183
Lars C SteneDepartment of Chronic Diseases and Ageing, Norwegian Institute of Public Health, Oslo, Norway.
Randi K JohnsonDepartment of Epidemiology, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO.
Marian J RewersBarbara Davis Center, University of Colorado Anschutz Medical Campus, Aurora, CO.
Jill M NorrisDepartment of Epidemiology, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO.ORCID 0000-0001-8674-2598
Colorado School of Public Health · USNorwegian Institute of Public Health · NOUniversity of Colorado Anschutz Medical Campus · USOslo University Hospital · NO

Funding

PILOT STUDY--SUBSTRATE METABOLISM IN EXTREMELY LOW BIRTH WEIGHT INFANTSP30DK048520 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI Edward L Melanson · 1995 to 2026
$32.6M
Natural History of Pre-Diabetic Autoimmunity (DAISY)R01DK032493 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI REWERS, MARIAN J · 1986 to 2024
$9.3M
Nutrigenetics & -genomics of Vitamin D and Omega-3 Fatty Acids in Type 1 DiabetesR01DK104351 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI NORRIS, JILL M · 2014 to 2018
$2.9M
NIDDK NIH HHS R01 DK032493NIDDK NIH HHS R01 DK104351
6 · The paper itself

Abstract

objectiveTo study the association of gluten intake with development of islet autoimmunity and progression to type 1 diabetes. RESEARCH DESIGN AND

methodsThe Diabetes Autoimmunity Study in the Young (DAISY) follows children with an increased risk of type 1 diabetes. Blood samples were collected at 9, 15, and 24 months of age, and annually thereafter. Islet autoimmunity was defined by the appearance of at least one autoantibody against insulin, IA2, GAD, or ZnT8 (zinc transporter 8) in at least two consecutive blood samples. Using food frequency questionnaires, we estimated the gluten intake (in grams per day) annually from 1 year of age. Cox regression modeling early gluten intake, and joint modeling of the cumulative gluten intake during follow-up, were used to estimate hazard ratios adjusted for confounders (aHR).

resultsBy August 2017, 1,916 subjects were included (median age at end of follow-up 13.5 years), islet autoimmunity had developed in 178 participants, and 56 of these progressed to type 1 diabetes. We found no association between islet autoimmunity and gluten intake at 1-2 years of age or during follow-up (aHR per 4 g/day increase in gluten intake 1.00, 95% CI 0.85-1.17 and 1.01, 0.99-1.02, respectively). We found similar null results for progression from islet autoimmunity to type 1 diabetes. Introduction of gluten at <4 months of age was associated with an increased risk of progressing from islet autoimmunity to type 1 diabetes compared with introduction at 4-5.9 months (aHR 8.69, 95% CI 1.69-44.8).

conclusionsOur findings indicate no strong rationale to reduce the amount of gluten in high-risk children to prevent development of type 1 diabetes.

Indexed as

AutoimmunityAutoantibodiesChild, PreschoolDiabetes Mellitus, Type 1Diet SurveysDisease ProgressionEatingFemaleFollow-Up StudiesGlutensHumansInfantIslets of LangerhansLongitudinal StudiesMaleRisk FactorsAutoantibodiesGlutens

Identifiers

PMID30796108
PMCPMC6489103
OpenAlexW2916313168

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.